The objective for this study is threefold. The first goal is to objectify differences in brain function between patients and normal controls. The second objective is to support preliminary findings that the combination of CBT/PMT is an effective…
ID
Source
Brief title
Condition
- Psychiatric disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Main study parameters:
- Change in symptom severity as measured with the Amsterdam Misophonia Scale
(AMISS) and Clinical Global Impression Scale (CGI)
- fMRI
- EEG
- Neuropsychological paradigms
- Genetic outcomes
Secondary outcome
Psychiatric questionnaires (HARS, HDRS, IOA, AVL, SCL-90R)
Background summary
Rationale: Misophonia is a currently underrecognized and uninvestigated
condition in which specific sounds, commonly produced by human beings, trigger
impulsive aggressiveness in apparently normal people. The intensity of the
anger initiates a profound feeling of loss of self-control which causes
significant avoidant behaviour that result in limited social contacts and
functioning.
Recently, diagnostic criteria have been formulated by Schröder and Denys to
distinguish it as a separate psychiatric disorder. Subsequently, a pilot group
therapy consisting of cognitive behavioural therapy (CBT) and psychomotor
therapy (PMT), has been treated in the AMC, which resulted in significant
symptom reduction in the majority of the patients.
Study objective
The objective for this study is threefold. The first goal is to objectify
differences in brain function between patients and normal controls. The second
objective is to support preliminary findings that the combination of CBT/PMT is
an effective treatment for misophonia. In addition, we will determine the
effects of CBT/PMT on functional activation of the brain in misophonia
patients.The final goal is to determine the genetic and epigenetic factors
involved in misophonia and its treatment.
Study design
Study design: an open-label case-control study.
Study burden and risks
Patients:
- 10 weeks in a row, weekly CBT sessions. Daily homework assignments.
- before, after 5 weeks and after finishing therapy: psychiatric questionnaires
- bloodsamples will be taken before and after CBT treatment
Both patients and controls:
- Before and after treatment: two days of imaging (MRI and EEG)
Meibergdreef 9
1105 AZ Amsterdam
NL
Meibergdreef 9
1105 AZ Amsterdam
NL
Listed location countries
Age
Inclusion criteria
Symptoms of misophonia
18-65 yrs
Exclusion criteria
Major Depression
Anxiety disorders
Bipolar disorder
Autism Spectrum Disorders
Psychotic disorders
Epilepsia/CNS disorders
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL37726.018.11 |